Rep. Julie Johnson Sells Off Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Representative Julie Johnson (D-Texas) recently sold shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA). In a filing disclosed on March 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Walgreens Boots Alliance stock on February 12th. The trade occurred in the Representative’s “MERRILL LYNCH TAX EFFICIENT CORE” account.

Representative Julie Johnson also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Norfolk Southern (NYSE:NSC) on 2/25/2025.
• Purchased $1,001 – $15,000 in shares of Union Pacific (NYSE:UNP) on 2/25/2025.
• Purchased $1,001 – $15,000 in shares of Bank of New York Mellon (NYSE:BK) on 2/24/2025.
• Sold $1,001 – $15,000 in shares of BlackRock (NYSE:BLK) on 2/24/2025.
• Sold $1,001 – $15,000 in shares of The PNC Financial Services Group (NYSE:PNC) on 2/24/2025.
• Purchased $1,001 – $15,000 in shares of Progressive (NYSE:PGR) on 2/24/2025.
• Purchased $1,001 – $15,000 in shares of The Goldman Sachs Group (NYSE:GS) on 2/24/2025.
• Purchased $1,001 – $15,000 in shares of Capital One Financial (NYSE:COF) on 2/24/2025.
• Purchased $1,001 – $15,000 in shares of Capital One Financial (NYSE:COF) on 2/14/2025.
• Purchased $1,001 – $15,000 in shares of Progressive (NYSE:PGR) on 2/14/2025.

Walgreens Boots Alliance Price Performance

NASDAQ WBA opened at $11.26 on Friday. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. The stock’s fifty day moving average price is $10.79 and its 200 day moving average price is $9.75. Walgreens Boots Alliance, Inc. has a 1 year low of $8.08 and a 1 year high of $22.05. The company has a market cap of $9.73 billion, a price-to-earnings ratio of -1.10, a PEG ratio of 1.31 and a beta of 0.62.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. During the same period in the prior year, the firm earned $0.66 EPS. The firm’s revenue was up 7.6% on a year-over-year basis. As a group, equities research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the stock. Wolfe Research raised shares of Walgreens Boots Alliance to a “hold” rating in a research note on Monday, February 24th. Bank of America increased their target price on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a research note on Monday, January 13th. Truist Financial lowered their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research note on Friday, January 31st. Royal Bank of Canada increased their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research note on Wednesday, January 15th. Finally, Evercore ISI increased their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research note on Monday, January 13th. Four research analysts have rated the stock with a sell rating, eight have given a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $11.54.

Institutional Investors Weigh In On Walgreens Boots Alliance

Several institutional investors have recently bought and sold shares of WBA. Vanguard Group Inc. lifted its stake in Walgreens Boots Alliance by 2.7% in the 4th quarter. Vanguard Group Inc. now owns 86,335,084 shares of the pharmacy operator’s stock worth $805,506,000 after purchasing an additional 2,279,495 shares in the last quarter. State Street Corp lifted its stake in Walgreens Boots Alliance by 18.0% in the 3rd quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock worth $385,258,000 after purchasing an additional 6,569,223 shares in the last quarter. Invesco Ltd. raised its position in shares of Walgreens Boots Alliance by 8.8% during the 4th quarter. Invesco Ltd. now owns 32,572,567 shares of the pharmacy operator’s stock valued at $303,902,000 after buying an additional 2,631,332 shares during the period. Geode Capital Management LLC raised its position in shares of Walgreens Boots Alliance by 5.2% during the 4th quarter. Geode Capital Management LLC now owns 20,779,254 shares of the pharmacy operator’s stock valued at $194,082,000 after buying an additional 1,020,587 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its position in shares of Walgreens Boots Alliance by 19.9% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator’s stock valued at $122,737,000 after buying an additional 2,185,950 shares during the period. 58.59% of the stock is currently owned by institutional investors and hedge funds.

About Representative Johnson

Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas’ 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.

Johnson (Democratic Party) ran for election to the U.S. House to represent Texas’ 32nd Congressional District. She won in the general election on November 5, 2024.

Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson’s career experience includes working as an attorney.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.